BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Kaken Pharmaceuticals and ChemDiv, Inc. Partner in Drug Discovery Deal


2/26/2007 12:21:25 PM

SAN DIEGO, Feb. 26 /PRNewswire/ -- ChemDiv, Inc. of San Diego, CA, USA, and Kaken Pharmaceutical Co., Ltd. of Tokyo, Japan have announced today that they entered into a joint Drug Discovery collaboration involving undisclosed therapeutic targets.

ChemDiv is to produce lead candidates employing its Discovery outSource(TM) platform, including proprietary rational design, extensive medicinal chemistry and pre-clinical biology capabilities.

The designed chemical libraries will be screened at ChemDiv on Kaken's drug targets with a subsequent lead optimization effort.

Dr. Motoyuki Yajima, Executive Managing Director of Research and Development of Kaken commented: "We are delighted to be able to work with ChemDiv, as this collaboration combines the complementary skills of both companies to create new compounds to our innovative targets. We are very optimistic and happy to have found such a capable partner in ChemDiv."

Dr. Ilya Okun, VP Biology and CTO of ChemDiv, Inc. said: "We established and partnered a turnkey lead discovery platform based on ChemDiv's pre-clinical development services. That includes assay development and validation, screening and lead candidate characterization in secondary assays, animal efficacy models, PK and Tox. We are proud to further expand our successful collaboration with Kaken."

About Kaken:

Kaken Pharmaceutical Co., Ltd. (www.kaken.co.jp) traces back to the Institute of Physical & Chemical Research (Riken), which was established in 1917. The company entered the pharmaceutical business with penicillin and streptomycin, which were manufactured using Riken's technology in 1948. Kaken has since broadened its scope of activities through merger and alliance and has a presence in internal medicine, orthopedics and dermatology. Kaken has advanced its market presence by providing new drugs discovered with its own technology and through partnership and in-licensing. Kaken's commitment to "bringing smile to everyone" entails providing superior pharmaceuticals that improve patients' quality of life.

About ChemDiv, Inc.

ChemDiv (www.chemdiv.com) is a global chemistry-driven contract research organization focused on delivery of scientific innovation, identifying and delivering pre-clinical opportunities and services for life science partners, and merging industrial and academic efforts to bring new approaches to the treatment of life-threatening diseases. For over 16 years ChemDiv has provided Discovery outSource(TM) solutions, including medicinal and synthetic chemistry, pre-clinical development, screening libraries and global logistics. The ChemDiv international research team encompasses 550 chemists and biologists in San Diego and Moscow based R&D centers.

Kaken Pharmaceutical Co., Ltd.; ChemDiv, Inc.

CONTACT: Ron Demuth, General Manager of ChemDiv, Inc., +1-858-794-4860, orfax, +1-858-794-4931



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES